SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
Agreement provides dedicated commercial channel for REZENOPY ™ across approximately 2,000 OTP (Opioid Treatment Program) Clinics and other Addiction Treatment Center Networks in the United States
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Air Canada Receives Gold Brandon Hall Group Excellence Award for Leadership Development Program
- Air Canada remporte la médaille d’or aux Prix d’excellence du Brandon Hall Group pour son programme de perfectionnement du leadership
- Árshlutauppgjör Garðabæjar endurspeglar krefjandi aðstæður
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →